MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
12.07
-1.32
-9.86%
Closed 16:00 05/30 EDT
OPEN
12.61
PREV CLOSE
13.39
HIGH
12.84
LOW
11.90
VOLUME
191.83K
TURNOVER
1.66M
52 WEEK HIGH
21.28
52 WEEK LOW
7.39
MARKET CAP
2.09B
P/E (TTM)
-5.6675
1D
5D
1M
3M
1Y
5Y
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 16h ago
Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday
Benzinga · 18h ago
BRIEF-Hutchmed (China) Says U.S. FDA Granted Priority Review Of New Drug Application For Fruquintinib
Reuters · 2d ago
10 Stocks Reacting To April PCE: Marvell Technology Leads The Rally
Benzinga · 4d ago
Hutchmed (China) Limited: Report of foreign issuer
Press release · 4d ago
Takeda, Hutchmed Say FDA Grants Priority Review to New Application of Fruquintinb for Treatment of Colorectal Cancer
Takeda, Hutchmed Say FDA Grants Priority Review to New Application of Fruquintinb for Treatment of Colorectal Cancer
MT Newswires · 5d ago
HUTCHMED Highlights Presentations At The 2023 ASCO Annual Meeting
Benzinga · 5d ago
Takeda And HUTCHMED Announce New Drug Application For Fruquintinib For Treatment Of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Benzinga · 5d ago
More
About HCM
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.

Webull offers kinds of HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ:HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.